Insight Molecular Diagnostics Inc. 8-K

What Happened
Insight Molecular Diagnostics, Inc. (IMDX) filed a Form 8-K on February 11, 2026 (Accession No. 0001493152-26-006117) disclosing under Item 7.01 that it will, from time to time, present and use a slide presentation with investors and analysts. The slide deck is furnished as Exhibit 99.1 to the filing. The company says it has no obligation to update, supplement or amend the furnished materials.

Key Details

• Filing date: February 11, 2026 (Form 8-K, Item 7.01: Regulation FD Disclosure).
• Exhibit: 99.1 — Investor presentation (furnished with the 8-K).
• Company statement: presentation may be used at one or more investor/analyst meetings and will not necessarily be updated.
• No earnings, executive changes, mergers, or other material financial items were reported in this filing.

Why It Matters
Furnishing an investor presentation under Regulation FD makes the company’s slides publicly available and ensures material investor communications are disclosed broadly. Retail investors should review the attached Exhibit 99.1 for any updates on strategy, product pipeline, or financial data that could inform investment decisions. This filing does not itself report quarterly results, executive changes, or other material corporate actions.